You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
17β-estradiol reduced depressive and somatic symptoms in perimenopausal women

https://doi.org/10.1136/ebm.7.1.21

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    (2001) Arch Gen Psychiatry 58, 529. Soares CN, Almeida OP, Joffe H. , et al. . Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women. A double-blind, randomized, placebo-controlled trial.. Jun;. :. –34.
    OpenUrlCrossRefPubMedWeb of Science

    
 
 QUESTION: In perimenopausal women with clinically important depressive disorders, does 17β-estradiol decrease depressive symptoms?

    Design

    12 week randomised (allocation concealed*), blinded {clinicians, patients, outcome assessors, and statisticians}†,* placebo controlled trial.

    Setting

    A gynaecological clinic and psychiatric outpatient clinic in São Paulo, Brazil.

    Patients

    50 women who were 40 to 55 years of age (mean age 50 y); had a history of menstrual cycle irregularity or amenorrhoea for < 12 months; had a serum concentration of follicle-stimulating hormone > 25 IU/l; and had been diagnosed with major depressive disorder, dysthymic disorder, or minor depressive disorder. Exclusion criteria were medical illness; hormone replacement therapy or psychoactive drug use in the previous 3 months; or presence of psychotic features or suicidal or severe aggressive behaviour. Follow up was 90%.

    Intervention

    Patients were allocated to a 17β-estradiol patch, 100 …

    View Full Text